Evidence map›Paper›PMID 25338001›Full record

ArticlePloS one2014

Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis.

Haibo Song, Fei Wu, Yuan Zhang, Yuzhu Zhang, Fang Wang, Miao Jiang, Zhongde Wang, Mingxiang Zhang, Shiwu Li, Lijun Yang and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 127 citations in OpenAlex.

  1. Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of Adipokines in the Control of Pituitary Functions.Animals : an open access journal from MDPI · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. A Bibliometric Analysis of the Literature on Irisin from 2012-2021.International journal of environmental research and public health · 2022
    Review
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Haibo SongCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China; Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China; Center for Reproductive Medicine, Zibo Maternal and Child health hospital, Zibo, P.R.China.
Fei WuCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China; Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Yuan ZhangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China; Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Yuzhu ZhangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China; Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Fang WangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China.
Miao JiangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China.
Zhongde WangCenter for Reproductive Medicine, Zibo Maternal and Child health hospital, Zibo, P.R.China.
Mingxiang ZhangShandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Shiwu LiCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China.
Lijun YangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China.
Xing Li WangShandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Taixing CuiShandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China; Department of Cell Biology and Anatomy, University of South Carolina, Columbia, South Carolina, United States of America.
Dongqi TangCenter for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan, P.R.China; Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital of Shandong University, Jinan, P.R.China.
Qilu Hospital of Shandong University · CNSecond Hospital of Shandong University · CNThe Fourth People's Hospital of Zibo City · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irisin is a newly discovered myokine that links exercise with metabolic homeostasis. It is involved in modest weight loss and improves glucose intolerance. However, the direct effects and mechanisms of irisin on vascular endothelial cells (ECs) are not fully understood. In the current study, we demonstrated that irisin promoted Human Umbilical Vein Endothelial Cell (HUVEC) proliferation. It was further demonstrated that this pro-proliferation effect was mediated by irisin-induced activation of extracellular signal-related kinase (ERK) signaling pathways. Inhibition of ERK signaling with U0126 decreased the pro-proliferation effect of irisin on HUVECs. It was also demonstrated that irisin reduced high glucose-induced apoptosis by up-regulating Bcl-2 expression and down-regulating Bax, Caspase-9 and Caspase-3 expression. In summary, these results suggested that irisin plays a novel role in sustaining endothelial homeostasis by promoting HUVEC proliferation via the ERK signaling pathway and protects the cell from high glucose-induced apoptosis by regulating Bcl-2,Bax and Caspase expression.

Indexed as

Apoptosisbcl-2-Associated X ProteinButadienesCaspase 3Caspase 9Cell ProliferationExtracellular Signal-Regulated MAP KinasesFibronectinsGene Expression RegulationGlucoseHumansHuman Umbilical Vein Endothelial CellsNitrilesProtein Kinase InhibitorsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanButadienesCaspase 3Caspase 9Extracellular Signal-Regulated MAP KinasesFibronectinsFNDC5 protein, humanGlucoseNitrilesProtein Kinase InhibitorsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsU 0126

Identifiers

PMID25338001
PMCPMC4206299
OpenAlexW2090974810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.